Anzeige
Mehr »
Samstag, 02.08.2025 - Börsentäglich über 12.000 News
Das Antimon-Erwachen: Warum dieser übersehene kanadische Explorer eine der hochgradigsten Entdeckungen Nordamerikas besitzen könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVT8 | ISIN: CH1125843347 | Ticker-Symbol: 90B
Frankfurt
01.08.25 | 08:02
2,720 Euro
-2,16 % -0,060
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SOPHIA GENETICS SA Chart 1 Jahr
5-Tage-Chart
SOPHIA GENETICS SA 5-Tage-Chart
RealtimeGeldBriefZeit
2,7002,78013:04
2,6202,82001.08.

Aktuelle News zur SOPHIA GENETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.07.Bioz, Inc.: Turning Proof Into Power: Bioz Partners With SOPHiA GENETICS to Enhance Scientific Transparency via Custom Integration188PALO ALTO, CALIFORNIA / ACCESS Newswire / July 15, 2025 / Bioz, Inc., the AI-powered solution revolutionizing how scientific companies present product evidence, is excited to announce its partnership...
► Artikel lesen
11.07.SOPHiA GENETICS SA - S-8, Securities to be offered to employees in employee benefit plans3
27.06.Sophia Genetics launches podcast to decode data- and AI-driven medical innovation4
18.06.SOPHiA GENETICS SA - 6-K, Report of foreign issuer2
27.05.MEXC lists SOPH with $40K SOPH and $50K USDT prize pool2
SOPHIA GENETICS Aktie jetzt für 0€ handeln
27.05.MEXC Announces the Listing of Sophon (SOPH) with $40,000 in SOPH and 50,000 USDT Prize Pool361VICTORIA, Seychelles, May 27, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency exchange, will list Sophon (SOPH) on May 28, 2025 (UTC).To celebrate the listing, MEXC is launching...
► Artikel lesen
16.05.SOPHiA GENETICS SA - 6-K, Report of foreign issuer1
06.05.SOPHiA GENETICS SA - 6-K, Report of foreign issuer3
06.05.SOPHiA GENETICS Reports First Quarter 2025 Results211BOSTON and ROLLE, Switzerland, May 6, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine...
► Artikel lesen
28.04.SOPHia Genetics expands testing partnership with AstraZeneca4
28.04.SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR338BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today...
► Artikel lesen
28.04.SOPHiA GENETICS expands AstraZeneca liquid biopsy test3
28.04.SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR160BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader...
► Artikel lesen
08.04.Precision for Medicine geht mit SOPHiA GENETICS eine Partnerschaft ein, um seine Biopharma-Dienstleistungen mit der SOPHiA DDM-Plattform und ihren Liquid-Biopsy-Funktionen zu erweitern80Die Partnerschaft integriert fortschrittliche KI-gesteuerte Analysen und Lösungen für klinische Studien und ermöglicht es Biopharmaunternehmen, die Entwicklung von...
► Artikel lesen
08.04.Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM Platform and its Liquid Biopsy Capabilities330The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster. BETHESDA...
► Artikel lesen
18.03.SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC399BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic...
► Artikel lesen
05.03.BTIG cuts Sophia Genetics stock price target to $5, maintains buy4
04.03.SOPHiA Genetics reports mixed Q4 results; initiates FY25 outlook1
04.03.SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results328BOSTON and ROLLE, Switzerland, March 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine...
► Artikel lesen
04.03.SOPHiA GENETICS SA - 20-F, Annual and transition report of foreign private issuers-
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1